Archive for February 2023
CEO of Nixon Peabody discusses DEI and the future of the legal industry
Stephen Zubiago has helmed Nixon Peabody LLP for two years now, after a decade of overseeing the Boston-based firm’s Business and Finance department. Read More
Read MoreNortheastern grad gets National Science Foundation funding for tactile sign language robot
Boston-based Tatum Robotics is one of the first companies working on new, innovative technologies specifically for the DeafBlind community. Read More
Read MoreAmid tech layoffs, Tripadvisor’s headcount grew 15% last year
One of the businesses that was hit particularly hard in the first phase of the pandemic is ramping up hiring again. Read More
Read MoreCompany founded to make ‘radically’ cheap drugs lays off 66
It was just a few months ago that EQRx Inc. moved away from its original, sweeping vision to create "radically" cheap drugs. Read More
Read MoreNew Bedford Whaling Museum is telling the story of long-ago industry in modern-day ways
Under CEO Amanda McMullen, the New Bedford Whaling Museum is telling a broader story about history and has its eyes on an expansion as membership grows. Read More
Read MoreHead of woman-owned food business is focused on company’s legacy
Nancy Matheson-Burns, who runs Dole & Bailey, recognized as a child the sense of purpose she felt working at the food distributor, which dates back a founding in 1868 at Faneuil Hall. Read More
Read MoreMentoring Monday: Advice from some of Boston’s female mentors
The Boston Business Journal asked business leaders participating in Mentoring Monday about mentorship. Here’s what they said. Read More
Read MoreLowell General Hospital CEO to step down this year
Jody White first joined the hospital 20 years ago, and was named CEO in 2017. Read More
Read MoreGannett eliminated 20% of its journalism jobs in 2022
The newspaper chain’s annual filing revealed that the company employed 3,900 journalists at the end of 2022. That’s down 20% from the previous year. Read More
Read MoreCambridge biotech Jounce to cut staff, merge with U.K. drug developer
A Cambridge-based cancer company and longtime partner of pharma giant Gilead Sciences Inc. is merging with another firm, one day after announcing it would lay off most of its staff. Read More
Read More